Search results - 7 results
Factors underlying COVID-19 booster vaccine uptake among adults in Belgium
Publication Type: Peer reviewed scientific article Authors: Elias Vermeiren; Joris Van Loenhout; Léonore Nasiadka; Veerle Stouten; Matthieu Billuart; Izaak Van Evercooren; Lucy Catteau; Pierre Hubin Source: BMC Res Notes, Volume 16, Issue 1 (2023) Keyword ...
Monitoring COVID-19 vaccine effectiveness against COVID-19 hospitalisation and death using electronic health registries in ≥65 years old population in six European countries, October 2021 to November 2022.
Publication Type: Peer reviewed scientific article Authors: Kislaya, Irina; Sentís, Alexis; Starrfelt, Jostein; Nunes, Baltazar; Martínez-Baz, Iván; Nielsen, Katrine Finderup; AlKerwi, Ala'a; Toon Braeye; Fontán-Vela, Mario; Bacci, Sabrina; Meijerink ...
Characterisation of tetanus monoclonal antibodies as a first step towards the development of an in vitro vaccine potency immunoassay.
in these products is of utmost importance for product safety and clinical effect. Immunochemical methods that measure consistency of antigen content and quality, potentially as an indicator of potency, ...
Characterisation of diphtheria monoclonal antibodies as a first step towards the development of an in vitro vaccine potency immunoassay.
Kwaliteit van vaccins en bloedproducten Quality of vaccines and blood products Manuscript versions: DOI: https://pubmed.ncbi.nlm.nih.gov/33454193/ File: Version: Published Full text access: Public Access ...
Immunogenicity and protective efficacy of DNA vaccines encoding secreted and non-secreted forms of Mycobacterium tuberculosis Ag85A.
Publication Type: Peer reviewed scientific article Authors: Baldwin, S L; D'Souza, C D; Orme, I M; Liu, M A; Huygen, K; Denis, O; Tang, A; Zhu, L; Montgomery, D; Ulmer, J B Source: Tuber Lung Dis, Volume 79, Issue 4, Number 259, p.251-9 (1999) Keywor ...
Immunogenicity and efficacy of a tuberculosis DNA vaccine encoding the components of the secreted antigen 85 complex.
Publication Type: Peer reviewed scientific article Authors: Lozes, E; Huygen, K; Content, J; Denis, O; Montgomery, D L; Yawman, A M; Vandenbussche, P; Van Vooren, J P; Drowart, A; Ulmer, J B; Liu, M A Source: Vaccine, Volume 15, Issue 8, Number 833, p.830 ...
Differences in Antigenic Structure of Inactivated Polio Vaccines Made From Sabin Live-Attenuated and Wild-Type Poliovirus Strains: Impact on Vaccine Potency Assays.
Several manufacturers use Sabin OPV strains for IPV production (sIPV), rather than the usual wild-type strains used for conventional IPV (cIPV). However, in contrast to cIPV, potency assays for sIPV have ...